|
Other anticoagulants
Citations 71-80 of 93 total displayed.
|
Past content
(since Jan 2001):
|
- Review: Clinical Cardiology: New Frontiers
Acute Pulmonary Embolism: Part I: Epidemiology, Pathophysiology, and Diagnosis
- Samuel Z. Goldhaber and C. Gregory Elliott
Circulation 2003;108:2726-2729, doi:10.1161/01.CIR.0000097829.89204.0C
[Full text]
- Brief Rapid Communications
Anaphylactic and Anaphylactoid Reactions Associated With Lepirudin in Patients With Heparin-Induced Thrombocytopenia
- A. Greinacher, N. Lubenow, and P. Eichler
Circulation 2003;108:2062-2065; published online before print as doi:10.1161/01.CIR.0000096056.37269.14
[Abstract]
[Full text]
- Articles
Anaphylactic and Anaphylactoid Reactions Associated With Lepirudin in Patients With Heparin-Induced Thrombocytopenia
- A. Greinacher, N. Lubenow, and P. Eichler
Circulation published October 20, 2003, doi:10.1161/01.CIR.0000096056.37269.14
[Abstract]
- Images in Cardiovascular Medicine
Recurrent Myocardial Infarction in a Patient With Paroxysmal Nocturnal Hemoglobinuria
- Fabien Hyafil, Gilles Montalescot, Zahir Amoura, Rémi Choussat, Jean-Philippe Collet, and Jean-Charles Piette
Circulation 2003;108:e91-92e, doi:10.1161/01.CIR.0000091885.93828.DE
[Full text]
- Clinical Investigations and Reports
Relationship of Activated Partial Thromboplastin Time to Coronary Events and Bleeding in Patients With Acute Coronary Syndromes Who Receive Heparin
- Sonia S. Anand, Salim Yusuf, Janice Pogue, Jeffrey S. Ginsberg, and Jack Hirsh
Circulation 2003;107:2884-2888; published online before print as doi:10.1161/01.CIR.0000077530.53367.E9
[Abstract]
[Full text]
- Articles
Relationship of Activated Partial Thromboplastin Time to Coronary Events and Bleeding in Patients With Acute Coronary Syndromes Who Receive Heparin
- Sonia S. Anand, Salim Yusuf, Janice Pogue, Jeffrey S. Ginsberg, Jack Hirsh on Behalf of the Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators
Circulation published June 9, 2003, doi:10.1161/01.CIR.0000077530.53367.E9
[Abstract]
- AHA/ACC Scientific Statement
American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy
- Jack Hirsh, Valentin Fuster, Jack Ansell, and Jonathan L. Halperin
Circulation 2003;107:1692-1711, doi:10.1161/01.CIR.0000063575.17904.4E
[Full text]
- Clinical Investigations and Reports
Ability of Recombinant Factor VIIa to Reverse the Anticoagulant Effect of the Pentasaccharide Fondaparinux in Healthy Volunteers
- Nick R. Bijsterveld, Arno H. Moons, S. Matthijs Boekholdt, Benien E. van Aken, Hein Fennema, Ron J.G. Peters, Joost C.M. Meijers, Harry R. Büller, and Marcel Levi
Circulation 2002;106:2550-2554; published online before print as doi:10.1161/01.CIR.0000038501.87442.02
[Abstract]
[Full text]
- Correspondence
Every Acronym Should Be Defined When It First Appears in a Publication
- Tsung O. Cheng
Circulation 2002;106:e134, doi:10.1161/01.CIR.0000036542.05270.A9
[Full text]
- Clinical Investigations and Reports
Ability of Recombinant Factor VIIa to Reverse the
Anticoagulant Effect of the Pentasaccharide Fondaparinux in
Healthy Volunteers
- Nick R. Bijsterveld, Arno H. Moons, S. Matthijs Boekholdt, Benien E. van Aken, Hein Fennema, Ron J.G. Peters, Joost C.M. Meijers, Harry R. Büller, and Marcel Levi
Circulation published October 21, 2002, doi:10.1161/01.CIR.0000038501.87442.02
[Abstract]
|
|
